Predicting the cause of temporary double vision
Official title: Development and Validation of a Predictive Score for the Ischemic Etiology of a Transient Diplopia
Run by Fondation Ophtalmologique Adolphe de Rothschild · NCT02576925 · Data updated 2026-11-12
This study is trying to create a scoring system to help doctors figure out the urgent causes of temporary double vision that lasts less than a day.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 220 (estimated) |
| Sponsor | Fondation Ophtalmologique Adolphe de Rothschild Research network |
| Locations | 2 sites (Paris and 1 other locations) |
| Status | Recruiting |
| Started | September 24, 2015 |
| Main results expected | February 23, 2027 |
| Study ends | March 23, 2027 |
| Registry record updated | September 9, 2026 |
| Trial ID | NCT02576925 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are individuals who have experienced transient diplopia lasting less than 24 hours within the past 8 days.
✕Probably not a fit
Patients with permanent or non-transient diplopia may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to develop a clinical score to help clinicians identify the ischemic etiology of transient diplopia, which is defined as double vision lasting less than 24 hours. By conducting thorough clinical, ophthalmological, and neurological evaluations, the study seeks to differentiate between various causes of transient diplopia, particularly focusing on those that require urgent care. The goal is to enhance diagnostic accuracy and improve patient management in cases of transient diplopia.
Why it matters
Potential benefit: If successful, this study could lead to quicker and more accurate diagnoses for patients experiencing transient diplopia, potentially improving outcomes in cases of ischemic origin.
How similar studies have gone: While the approach of developing a predictive score for transient diplopia is innovative, similar studies focusing on diagnostic scoring systems in ophthalmology have shown promise in improving clinical outcomes.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Transient diplopia (i.e. less than 24 hours) during the last 8 days Exclusion Criteria: \-
Where it's running
-
Hôpital Bichat
Paris, France Recruiting -
Fondation Ophtalmologique Adolphe de Rothschild
Paris, Île-de-France Region, France Recruiting
Study contacts
- Study coordinator: Michel Rosenheim, MD, DSc
- Email: mrosenheim@fo-rothschild.fr
- Phone: +33148036457
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
French validation of the SAHOT outcome tool after subarachnoid hemorrhage
This study tests whether a French version of the SAHOT questionnaire reliably measures outcomes in adults after subarachnoid hemorrhage.
-
Blood RNA biomarkers for ALS using neuron-derived extracellular vesicles
This will try to see if RNA signatures in neuron-derived extracellular vesicles from blood can identify biomarkers in adults with suspected sporadic ALS compared with healthy volunteers.
-
Probenecid for cluster seizures during presurgical epilepsy monitoring
This trial tests whether probenecid can help control clusters of seizures in people with focal epilepsy during presurgical video-EEG monitoring.
-
Onset of myopia in children who are not yet myopic
This study follows children aged 4 to under 9 with no myopia to see how many become nearsighted over time and what factors might influence that shift.
-
Using virtual reality to measure progress during low vision rehabilitation
This project will test a 20-minute virtual reality test (VisionumVR on a Meta Quest 3) to measure functional vision in people with low vision who are starting or undergoing orthoptic rehabilitation.
-
Renal Involvement in Wilson's Disease
This study tests how Wilson's disease affects the kidneys and who might be at risk for kidney problems.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.